Troika Media Group Inc
Change company Symbol lookup
Select an option...
TRKA Troika Media Group Inc
SXTC China SXT Pharmaceuticals Inc
NLTX Neoleukin Therapeutics Inc
BTBT Bit Digital Inc
BTB Bit Brother Ltd
AHI Advanced Human Imaging Ltd
ADTH AdTheorent Holding Company Inc
SOXL Direxion Daily Semiconductor Bull 3X Shares
RMED Ra Medical Systems Inc
ICD Independence Contract Drilling Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Communication Services : Media | Small Cap Growth
Company profile

Troika Media Group, Inc is a global marketing services company. The Company is engaged in leveraging data and technology to deliver integrated branding, marketing, media, and analytics solutions to its clients. It offers solutions to clients an approach in meeting their brand strategy, experiential marketing, and communications needs. The Company’s operating units include Troika Services, Inc. (Global), Troika Design Group, Inc. (Los Angeles), MissionCulture LLC (New York), Mission-Media Holdings Limited (London) and Mission Media USA Inc. The Company operates in New York, New Jersey, and London.

Price
Delayed
$0.716
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 870 shares is on pace to be much lighter than TRKA's 10-day average volume of 104,609 shares.

870

SHAREHOLDER ALERT: Weiss Law Reminds VEC, LLNW, VMW, and EBS Shareholders About Its Ongoing Investigations

3:38 pm ET June 3, 2022 (PR Newswire) Print

https://mma.prnewswire.com/media/1424445/WeissLaw_LLP_Logo.jpg

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.Weiss Law305 Broadway, 7th FloorNew York, NY 10007(212) 682-3025(888) 593-4771stockinfo@weisslawllp.com

Vectrus, Inc. (NYSE: VEC)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vectrus, Inc. (NYSE: VEC), in connection with the proposed acquisition of VEC by The Vertex Company ("Vertex"). Upon completion of the transaction, Vertex shareholders will own approximately 62% of the combined company, while VEC shareholders will own only approximately 38% of the combined company. If you own VEC shares and wish to discuss this investigation or your rights, please call or visit our website: https://www.weisslaw.co/news-and-cases/vec

Limelight Networks, Inc. (NASDAQ: LLNW)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Limelight Networks, Inc. (NASDAQ: LLNW), in connection with the proposed transaction with Edgecast, Inc. ("Edgecast"), a business unit of Yahoo. Upon completion of the transaction, Yahoo will receive approximately 72.2 million shares of LLNW common stock. Additionally, current LLNW shareholders will own approximately 68.1% of the combined company, while Yahoo will own approximately 31.9%. If you own LLNW shares and wish to discuss this investigation or your rights, please call or visit our website: https://www.weisslaw.co/news-and-cases/llnw

VMware, Inc. (NYSE: VMW)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of VMware, Inc. (NYSE: VMW), in connection with the proposed acquisition of VMW by Broadcom Inc. ("Broadcom"). Under the terms of the merger agreement, VMW shareholders will receive $142.50 in cash or 0.2520 shares of Broadcom common stock for each VMW share owned, representing implied per-share merger consideration of approximately $145.34 based upon Broadcom's June 2, 2022 closing price of $576.74. If you own VMW shares and wish to discuss this investigation or your rights, please call or visit our website: https://www.weisslaw.co/news-and-cases/vmw

Emergent BioSolutions Inc. (NYSE: EBS)

Weiss Law, a national shareholders' rights law firm, is investigating possible false claims, deceptive accounting and reporting practices, breaches of fiduciary duty, and violations of the federal securities laws by the Board of Directors and certain Company officers of Emergent BioSolutions Inc. (NYSE: EBS). According to a final report expected to be released today after a year-long investigation by the House of Representatives' Select Subcommittee on the Coronavirus Crisis, EBS, hired to produce hundreds of millions of coronavirus vaccine doses, hid from US Food and Drug Administration inspectors evidence of quality control problems in February 2021- six weeks before it alerted federal officials that 15 million doses were contaminated. If you own EBS shares and wish to discuss this investigation or your rights, please call or visit our website: https://www.weisslaw.co/news-and-cases/ebs

https://c212.net/c/img/favicon.png?sn=DC78723&sd=2022-06-03

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-vec-llnw-vmw-and-ebs-shareholders-about-its-ongoing-investigations-301561103.html

SOURCE Weiss Law

https://rt.prnewswire.com/rt.gif?NewsItemId=DC78723&Transmission_Id=202206031538PR_NEWS_USPR_____DC78723&DateId=20220603

comtex tracking

COMTEX_408163585/1005/2022-06-03T15:38:11

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.